Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (141-150 of 217) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118Benjamin W Corn, Jennifer Moughan, Jonathan P S Knisely, et al.
The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progressionKristen M Turner, Youting Sun, Ping Ji, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Cancer|August 28, 2003
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapyBouthaina S Dabaja, Peter McLaughlin, Chul S Ha, et al.
Oncogene|March 12, 2004
A novel E1A-E1B mutant adenovirus induces glioma regression in vivoCandelaria Gomez-Manzano, Cristina Balague, Ramon Alemany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastomaChristopher E Pelloski, E Lin, Li Zhang, et al.
Journal of the National Cancer Institute|May 8, 2003
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathwayJuan Fueyo, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Pageof 22

Showing results (141-150 of 217) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118Benjamin W Corn, Jennifer Moughan, Jonathan P S Knisely, et al.
The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progressionKristen M Turner, Youting Sun, Ping Ji, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Cancer|August 28, 2003
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapyBouthaina S Dabaja, Peter McLaughlin, Chul S Ha, et al.
Oncogene|March 12, 2004
A novel E1A-E1B mutant adenovirus induces glioma regression in vivoCandelaria Gomez-Manzano, Cristina Balague, Ramon Alemany, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastomaChristopher E Pelloski, E Lin, Li Zhang, et al.
Journal of the National Cancer Institute|May 8, 2003
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathwayJuan Fueyo, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Pageof 22